HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,418 | -94.8% | 27,590 | -94.1% | 0.00% | – |
| Q2 2023 | $544,262 | -66.2% | 469,191 | -56.0% | 0.00% | – |
| Q1 2023 | $1,608,450 | -57.8% | 1,065,199 | -30.1% | 0.00% | -100.0% |
| Q4 2022 | $3,810,133 | -19.1% | 1,524,053 | +36.6% | 0.00% | 0.0% |
| Q3 2022 | $4,708,000 | +1193.4% | 1,115,796 | +755.8% | 0.00% | – |
| Q2 2022 | $364,000 | -79.1% | 130,384 | -57.1% | 0.00% | – |
| Q1 2022 | $1,739,000 | -89.6% | 304,072 | -83.4% | 0.00% | -100.0% |
| Q4 2021 | $16,729,000 | +421.5% | 1,832,419 | +510.5% | 0.00% | – |
| Q3 2021 | $3,208,000 | -10.6% | 300,129 | +29.8% | 0.00% | – |
| Q2 2021 | $3,588,000 | -72.3% | 231,156 | -71.1% | 0.00% | -100.0% |
| Q1 2021 | $12,972,000 | -21.3% | 800,278 | +2.8% | 0.00% | -25.0% |
| Q4 2020 | $16,474,000 | +533.4% | 778,380 | +343.4% | 0.00% | +300.0% |
| Q3 2020 | $2,601,000 | -71.2% | 175,537 | -71.4% | 0.00% | -75.0% |
| Q2 2020 | $9,039,000 | -55.2% | 614,574 | -64.2% | 0.00% | -55.6% |
| Q1 2020 | $20,165,000 | -55.4% | 1,717,606 | -10.7% | 0.01% | -55.0% |
| Q4 2019 | $45,175,000 | +41.8% | 1,922,350 | +11.7% | 0.02% | +42.9% |
| Q3 2019 | $31,848,000 | +23.1% | 1,721,500 | +23.7% | 0.01% | +27.3% |
| Q2 2019 | $25,871,000 | -22.1% | 1,391,638 | +2.5% | 0.01% | -35.3% |
| Q1 2019 | $33,190,000 | -52.8% | 1,358,024 | -49.9% | 0.02% | -56.4% |
| Q4 2018 | $70,253,000 | +12.5% | 2,708,303 | +37.3% | 0.04% | +39.3% |
| Q3 2018 | $62,444,000 | +17.4% | 1,972,980 | +44.1% | 0.03% | +7.7% |
| Q2 2018 | $53,180,000 | +90.4% | 1,368,860 | +35.3% | 0.03% | +73.3% |
| Q1 2018 | $27,929,000 | -5.6% | 1,011,913 | -38.1% | 0.02% | -16.7% |
| Q4 2017 | $29,600,000 | +781.5% | 1,635,364 | +686.6% | 0.02% | +800.0% |
| Q3 2017 | $3,358,000 | -81.7% | 207,894 | -84.3% | 0.00% | -86.7% |
| Q2 2017 | $18,310,000 | -4.9% | 1,321,976 | +3.0% | 0.02% | -16.7% |
| Q1 2017 | $19,255,000 | +620.9% | 1,283,679 | +529.5% | 0.02% | +800.0% |
| Q4 2016 | $2,671,000 | +454.1% | 203,933 | +628.3% | 0.00% | – |
| Q3 2016 | $482,000 | -87.5% | 28,000 | -86.9% | 0.00% | -100.0% |
| Q2 2016 | $3,854,000 | +625.8% | 213,517 | +663.8% | 0.00% | +300.0% |
| Q1 2016 | $531,000 | -94.0% | 27,953 | -91.5% | 0.00% | -90.0% |
| Q4 2015 | $8,784,000 | +687.8% | 328,985 | +819.4% | 0.01% | +900.0% |
| Q2 2015 | $1,115,000 | +389.0% | 35,784 | +127.9% | 0.00% | – |
| Q1 2015 | $228,000 | +74.0% | 15,703 | +20.3% | 0.00% | – |
| Q4 2014 | $131,000 | – | 13,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |